Sign in
4/A

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-020248

CBO & COO acquired 16,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Klein Lawrence Otto CBO & COO 2021-01-15 Option exercise +16,334 $14.43 $235,700 26,942 D
Loading xslF345X03/doc4a.xml…